Ammonia-n-13-01 (Ammonia N 13 01)
Ammonia N 13 Injection, Solution
Product Images NDC 76318-643
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ammonia N 13 (NDC 76318-643). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Massachusetts General Hospital, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Ammonia-n-13-02 (Ammonia N 13 02)
Ammonia N 13 Injection is a diagnostic drug that is administered intravenously. It is a sterile, non-pyrogenic solution that should be used within 45 minutes after the end of the synthesis. The solution is stored in a vial and each milliliter of the solution contains either 0.138 or 1.387 GBq of Ammonia N13. The drug should be stored at 25°C (17°F), with temperature excursions permitted to 15-30°C (59-86°F). The dosage of the drug should be calculated based on the date and time of calibration to ensure that the correct dosage is used. Finally, the drug should not be used if it is cloudy or contains particulate matter.*
Ammonia-n-13-vial-lbl (Ammonia N 13 Vial Lbl)
This is a description of Ammonia N13 Injection used for PET scans. It indicates the quantity available in mCi per mL at EOS and provides the Lot number. It also contains a warning label stating that the material is radioactive and should not be used if cloudy or containing particulate matter. The product is manufactured by MGH PET Center in Boston, Massachusetts.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
